A 60-year-old woman with sexual difficulties

JAMA

Volumn 297, Issue 6, 2007, Pages 620-633

  Potter, Jennifer E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CIPROFLOXACIN; CYCLOBENZAPRINE; ESTRADIOL; ESTRATEST; LISINOPRIL; METFORMIN; MONTELUKAST; PRAVASTATIN;

ADULT; AGING; ALLERGIC ASTHMA; ARTICLE; BACKACHE; CASE REPORT; DIABETES MELLITUS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HEALTH EDUCATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIBIDO DISORDER; LIFESTYLE MODIFICATION; MENOPAUSAL SYNDROME; MENOPAUSE; ORGASM DISORDER; PATIENT COUNSELING; PELVIC FLOOR MUSCLE TRAINING; POSTMENOPAUSE; PRIORITY JOURNAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL SATISFACTION; TREATMENT INDICATION; VAGINAL DRYNESS;

EID: 33846969550     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.6.620     Document Type: Article

References (122)

1. Cain VS, Johannes CB, Avis NE, et al. Sexual functioning and practices in a multiethnic study of midlife women: baseline results from SWAN. J Sex Res. 2003;40:266-276.
2. Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's Sexual Function and Dysfunction: Study, Diagnosis and Treatment. London, England: Taylor & Francis; 2006.
3. Pfaus JG, Scepkowski LA. The biologic basis for libido. Curr Sexual Health Rep. 2005;2:95-100.
4. Basson R. Pharmacotherapy for sexual dysfunction in women. Expert Opin Pharmacother. 2004;5:1045-1059.
5. Clayton AH. Sexual function and dysfunction in women. Psychiatr Clin North Am. 2003;26:673-682.
6. Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol. 2003;24:221-229.
7. Hallstrom T. Sexuality in the climacteric. Clin Obstet Gynaecol. 1977;4:227-239.
8. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril. 2001;76:456-460.
9. Sexuality in middle and later life fact sheet. Sexuality Information and Education Council of the United States Web site. http://www.siecus.org/pubs/fact /fact0018.html. Accessed January 15, 2007.
10. Kingsberg SA. The impact of aging on sexual function in women and their partners. Arch Sex Behav. 2002;31:431-437.
11. Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. J Womens Health Gend Based Med. 2000;9:S25-S32.
12. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: a literature review. Menopause. 2004;11:120-130.
13. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90:3847-3853.
14. Burger HG, Dudley EC, Cui J. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;85:2832-2838.
15. Gambera A, Scagliola P, Falsetti L, Sartori E, Bianchi U. Androgens, insulinlike growth factor-1 (IGF-1), and carrier proteins (SHBG, IGFBP-3) in postmenopause. Menopause. 2004;11:159-166.
16. Maruyama Y, Aoki N, Suzuki Y, Sinohara H, Yamamoto T. Variation with age in the levels of sex-steroid-binding plasma protein as determined by radioimmunoassay. Acta Endocrinol (Copenh). 1984;106:428-432.
17. Judd HL, Judd GE, Lucas WE, Yen SSC. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab. 1974;39:1020-1024.
18. Couzinet B, Meduri G, Lecce M, et al. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab. 2001;86:5060-5066.
19. Judd HL, Lucas WE, Yen SSC. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974;118:793-798.
20. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2000;85:645-651.
21. Nathorst-Boos J, von Schoultz B. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest. 1992;34:97-101.
22. Aziz A, Bergquist C, Nordholm L, Moller A, Silfverstolpe G. Prophylactic oophorectomy at elective hysterectomy: effects on psychological well-being at 1-year follow-up and its correlations to sexuality. Maturitas. 2005;51:349-357.
23. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med. 2006;3:212-222.
24. Hayes R, Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med. 2005;2:317-330.
25. Maas CP, Weijenborg PT, ter Kuile MM. The effect of hysterectomy on sexual functioning. Annu Rev Sex Res. 2003;14:83-113.
26. Kim DH, Lee YS, Lee ES. Alteration of sexual function after classic intrafascial supracervical hysterectomy and total hysterectomy. J Am Assoc Gynecol Laparosc. 2003;10:60-64.
27. Barber MD, Mullen KJ, Dowsett SA, Viktrup L. The impact of stress urinary incontinence on sexual activity in women. Cleve Clin J Med. 2005;72:225-232.
28. Park K. Animal models in investigation of female sexual function and dysfunction. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's Sexual Function and Dysfunction. London, England: Taylor & Francis; 2006:193-200.
29. Stimmel GL, Gutierrez MA. Sexual dysfunction and psychotropic medications. CNS Spectr. 2006;11:24-30.
30. Finger WW, Lund M, Slagle MA. Medications that may contribute to sexual disorders: a guide to assessment and treatment in family practice. J Fam Pract. 1997;44:33-43.
31. Dusing R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs. 2005;65:773-786.
32. Lewis C, Duncan LE, Balance DI, Pearson TA. Is sexual dysfunction in hypertensive women uncommon or understudied? Am J Hypertens. 1998;11:733-735.
33. Avis NE, Zhao X, Johannes CB. Correlates of sexual function among multiethnic middle-ages women: results from the Study of Women's Health Across the Nation (SWAN). Menopause. 2005;12:385-397.
34. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537-544.
35. Fugl-Meyer AR, Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74 year old Swedes. Scand J Sexology. 1999;2:79-105.
36. Richters J, Grulich AE, de Visser RO, Smith AMA, Rissel CE. Sex in Australia: sexual difficulties in a representative sample of adults. Aust N Z J Public Health. 2003;27:164-170.
37. Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav. 2003;32:193-208.
38. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav. 1994;23:627-643.
39. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191-208.
40. Berman LA, Berman JR, Werbin T, Chabra S, Goldstein I. The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction. J Sex Marital Ther. 2001;27:427-433.
41. Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med. 2002;11:277-289.
42. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28:317-330.
43. Derogatis L, Rust J, Golombok S, et al. Validation of the profile of female sexual function (PFSF) in surgically and naturally menopausal women. J Sex Marital Ther. 2004;30:25-36.
44. Hatzichristou D, Rosen RC, Broderick G, et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med. 2004;1:49-57.
45. Basson R. Sexual desire and arousal disorders in women. N Engl J Med. 2006;354:1497-1506.
46. Nusbaum MR, Hamilton CD. The proactive sexual health history. Am Fam Physician. 2002;66:1705-1712.
47. Lowenstein L, Yarnitsky D, Gruenwald I, et al. Does hysterectomy affect genital sensation? Eur J Obstet Gynecol Reprod Biol. 2005;119:242-245.
48. Park K, Ahn K, Chang JS, et al. Diabetes induced alteration of clitoral hemodynamics and structure in the rabbit. J Urol. 2002;168:1269-1272.
49. Newman DK. Assessment of the patient with overactive bladder. J Wound Ostomy Continence Nurs. 2005;32:S5-S10.
50. Guay AT. Screening for androgen deficiency in women: methodological and interpretive issues. Fertil Steril. 2002;77:S83-S88.
51. Davis SR, Davison SL, Donath A, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA. 2005;294:91-96.
52. Santoro N, Torrens J, Crawford S, et al. Correlates of circulating androgens in midlife women: the Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2005;90:4836-4845.
53. Nijland E, Davis S, Laan E, Schultz WW. Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction. J Sex Med. 2006;3:763-777.
54. Masters WH, Johnson VE. Human Sexual Inadequacy. Boston, Mass: Little Brown and Co; 1970.
55. Leiblum SR, Wiegel M. Psychotherapeutic interventions for treating female sexual dysfunction. World J Urol. 2002;20:127-136.
56. Schober JM, Meyer-Bahlburg HF, Ransley PG. Self-assessment of genital anatomy, sexual sensitivity and function in women: implications for genitoplasty. BJU Int. 2004;94:589-594.
57. Sudol KM, Phillips DM. Relative safety of sexual lubricants for rectal intercourse. Sex Transm Dis. 2004;31:346-349.
58. US Centers for Disease Control and Prevention. CDC Update: Questions and Answers: Male Latex Condoms to Prevent Sexual Transmission of HIV. Atlanta, Ga: National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention; April 1997.
59. Warnock JK, Swanson SG, Borel RW, et al. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women. Menopause. 2005;12:374-384.
60. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab. 1991;72:336-343.
61. Nathorst-Boos J, Wiklund I, Mattsson L, Sandin K, Von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? a double-blind placebo-controlled study in postmenopausal women. Acta Obstet Gynecol Scand. 1993;72:656-660.
62. Wiklund I, Karlberg J, Mattsson L. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol. 1993;168:824-830.
63. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003;348:1839-1854.
64. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701-1712.
65. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
66. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2003;(4):CD001500.
67. Long CY, Liu CM, Hsu SC, et al. A randomized, comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause. 2006;13:737-743.
68. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive desire disorder. Fertil Steril. 2003;79:1341-1352.
69. Shifren JL, Braunstein G, Simon J, et al. Transdermal testerone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682-688.
70. Braunstein GD, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med. 2005;165:1582-1589.
71. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol. 2005;105:944-952.
72. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90:5226-5233.
73. Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause. 2006;13:770-779.
74. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med. 2002;11:367-377.
75. Berman JR, Berman LA, Toler SM, et al. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J Urol. 2003;170:2333-2338.
76. Masand PS, Ashton AK, Gupta S, Frank B. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry. 2001;158:805-807.
77. DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry. 2005;66:844-848.
78. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keler A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004;65:62-67.
79. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004;24:339-342.
80. Modelska K, Litwack S, Ewing SK, Yaffe K. Endogenous estrogen levels affect sexual function in elderly post-menopausal women. Maturitas. 2004;49:124-133.
81. Dennerstein L, Burrows GD, Wood C, Hyman G. Hormones and sexuality: effect of estrogen and progestogen. Obstet Gynecol. 1980;56:316-322.
82. Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual functioning of women through the natural menopause transition. Fertil Steril. 2005;84:174-180.
83. Serin IS, Ozcelik B, Basbug M, Aygen E, Kula M, Erez R. Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels. Eur J Obstet Gynecol Reprod Biol. 2001;99:222-225.
84. Menon DV, Vongpatanasin W. Effects of transdermal estrogen replacement therapy on cardiovascular risk factors. Treat Endocrinol. 2006;5:37-51.
85. Traish AM, Kim NN. Modulation of female genital sexual arousal by sex steroid hormones. In: Goldstein I, Meston CM, Davis SR, Traish AM, eds. Women's Sexual Function and Dysfunction: Study, Diagnosis and Treatment. London, England: Taylor & Francis; 2006:181-192.
86. Tuiten A, van Honk J, Verbaten R, Laan E, Everaerd W. Can sublingual testosterone increase subjective and physiological measures of laboratory-induced sexual arousal? Arch Gen Psychiatry. 2002;59:465-466.
87. Crandall C. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy. J Womens Health (Larchmt). 2002;11:857-877.
88. Martin PL, Yen SS, Burnier AM, Hermann H. Systemic absorption and sustained effects of vaginal estrogen creams. JAMA. 1979;242:2699-2700.
89. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord. 1988;14:177-187.
90. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 1995;21:227-236.
91. Dobs AS, Nguyen T, Pace C, Roberts CP. Differential effects of oral estrogen versus oral estrogen-androgen replacement on body composition in postmenopausal women. J Clin Endocrinol Metab. 2002;87:1509-1516.
92. Floter A, Nathorst-Boos J, Carlstrom K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric. 2002;5:357-365.
93. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in post-menopausal women dissatisfied with estrogen-only therapy: sexual behavior and neuroendocrine responses. J Reprod Med. 1998;43:847-856.
94. Davis SR, Goldstat R, Papalia MA, et al. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause. 2006;13:37-45.
95. Settle EC, Settle EC Jr. Bupropion sustained release: side effect profile. J Clin Psychiatry. 1998;59:32-36.
96. Berman JR, Berman LA, Lin H, et al. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther. 2001;27:411-420.
97. Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestroegenized women with acquired genital arousal disorder and impaired orgasm: a randomized controlled trial. BJOG. 2003;110:1014-1024.
98. Caruso S, Rugolo S, Agnello C, Intelisano G, DiMari L, Cianci A. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril. 2006;85:1496-1501.
99. Alboni P, Bettiol K, Fuca G, et al. Sexual activity with and without the use of sildenafil: risk of cardiovascular events in patients with heart disease. Ital Heart J. 2004;5:343-349.
100. Meston CM, Heiman JR. Ephedrine-activated physiological sexual arousal in women. Arch Gen Psychiatry. 1998;55:652-658.
101. Rosen RC, Phillips NA, Gendrano N, Ferguson DM. Oral phentolamine and female sexual arousal disorder: a pilot study. J Sex Marital Ther. 1999;25:137-144.
102. Rubio-Aurioles E, Lopez M, Lipezker M, et al. Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: a psychophysiological study. J Sex Marital Ther. 2002;28(suppl 1):205-215.
103. Islam A, Mitchell J, Rosen R, et al. Topical alprostadil in the treatment of FSAD. J Sex Marital Ther. 2001;27:531-540.
104. Padma-Nathan H, Brown C, Fendl J, Salem S, Yeager J, Harninger R. Efficacy and safety of topical alprostadil cream for the treatment of female sexual arousal disorder (FSAD): a double-blind, multicenter, randomized, and placebo-controlled trial. J Sex Marital Ther. 2003;29:329-344.
105. Bechara A, Bertolino MV, Casabe A, et al. Duplex Doppler ultrasound assessment of clitoral hemodynamics after topical administration of alprostadil in women with arousal and orgasmic disorders. J Sex Marital Ther. 2003;29(suppl 1):1-10.
106. Meston CM, Worcel M. The effects of yohimbine plus l-arginine glutamate on sexual arousal in postmenopausal women with sexual arousal disorder. Arch Sex Behav. 2002;31:323-332.
107. Gittelman MC, Liao QP, Song XH, Geng L, Wang XP, Mo J. A placebo-controlled, double-blind study of the efficacy and safety of an alprostadil topical cream in patients with female sexual arousal disorder. J Sex Med. 2006;3(suppl 3):224-286.
108. Billups KL. The role of mechanical devices in treating female sexual dysfunction and enhancing the female sexual response. World J Urol. 2002;20:137-141.
109. Wilson SK, Delk JR, Billups KL. Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device. J Gend Specif Med. 2001;4:54-58.
110. Bo K, Talseth T, Vinsnes A. Randomized controlled trial on the effect of pelvic floor muscle training on quality of life and sexual problems in genuine stress incontinent women. Acta Obstet Gynecol Scand. 2000;79:598-603.
111. Perkins J. Vaginal weights for assessment and training of the pelvic floor. J Wound Ostomy Continence Nurs. 1998;25:206-216.
112. Binks M, Kolotkin R, Ostbye T, et al. Changes in sexual quality of life in individuals undergoing weight loss treatment: a 2-year longitudinal study. Presented at: NAASO 2005 Annual Scientific Meeting; October 27, 2005; Vancouver, British Columbia.
113. Gerber JR, Johnson JV, Bunn JY, O'Brien SL. A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause. Fertil Steril. 2005;83:643-648.
114. Fourcroy JL. Female sexual dysfunction: potential for pharmacotherapy. Drugs. 2003;63:1445-1457.
115. Segraves RT. Emerging therapies for female sexual dysfunction. Expert Opin Emerg Drugs. 2003;8:515-522.
116. Hines TM. The G-spot: a modern gynecologic myth. Am J Obstet Gynecol. 2001;185:359-362.
117. Arlt W, Callies F, Allolio B. DHEA replacement in women with adrenal insufficiency - pharmocokinetics, bioconversion and clinical effects on well-being, sexuality and cognition. Endocr Res. 2000;26:505-511.
118. Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandronsterone (DHEA), DHEA sulfate, and aging: contribution of the DHEA Age Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000;97:4279-4284.
119. Rowland DL, Tai W. A review of plant-derived and herbal approaches to the treatment of sexual dysfunctions. J Sex Marital Ther. 2003;29:185-205.
120. Ito TY, Trant AS, Polan ML. A double-blind placebo-controlled study of Arginmax, a nutritional supplement for enhancement of female sexual function. J Sex Marital Ther. 2001;27:541-549.
121. American Psychiatric Association. DSMIV-TR: Diagnostic and Statistical Manual for Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 2000.
122. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. Geneva, Switzerland: World Health Organization; 1992.